IDIS

Showing 5 posts of 5 posts found.

Chief executive Peter George image

Clinigen buys Idis for £225 million

April 24, 2015
Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed

UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …

jeff_thomas_web

Quintiles president to chair Idis

September 13, 2013
Manufacturing and Production, Research and Development, Sales and Marketing IDIS, Quintiles, thomis

Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …

The specifics of early access programmes

December 3, 2010
Sales and Marketing Expanded Access Programs, IDIS, early access programmes, named patient programmes

With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …

Idis appoints Richard Greatorex

June 8, 2010
Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

IDIS and Ogilvy to promote named patient programme

April 28, 2009
Medical Communications, Sales and Marketing IDIS, Ogilvy

Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …

The Gateway to Local Adoption Series

Latest content